TNSC to invest in growing medical application, targets 30% of market in two years

TGR reports that Taiyo Nippon Sanso (TNSC) is to expand its production capacity of the Water-18O stable isotope, which is a raw material for a drug used in FDG-PET examinations. The company will establish a new production facility with a capacity of 200kg per year at its Sodegaura plant at Chiba Sanso Centre in Chiba Prefecture. ... Source: http://bit.ly/sWPFT4